Understanding the chemokine network has become one of the great challenges for
researchers interested in inflammatory mechanisms and inflammation-based diseases. The
complexity and diversity of the system provide not only a daunting task for its comprehension
but also numerous opportunities for development of new, targeted therapies. It is now certain
that chemokines are involved as important mediators of allergic inflammation; the fine details
and scope of their roles are now under investigation. Presumably, because of distinct …